Encephalopathy

.. Background: Encephalopathy occurs in 10–40% of patients treated with high-dose ifosfamide. Proposed risk factors for encephalopathy include hepatic or renal dysfunction, brain metastases, ...

.. (HIV) encephalopathy followed in the Women and Infants Transmission Study cohort.

STUDY DESIGN: Retrospective review of clinical and immunologic staging of perinatally HIV-infected ...

Encephalopathy and encephalitis are major and devastating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus-associated central nervous system complications. Hypoxic/metabolic ...

.. of encephalopathy, especially subclinical, on quality of life are incompletely understood. Therefore, the aim of our study was to define the effects of encephalopathy on specific domains ...

.. of encephalopathy in full-term newborns.

DESIGN: Population-based case-control study.

SETTING: Washington State births from 1994 through 2002 recorded in the linked Washington State Birth ...

.. necrotizing encephalopathy of childhood is poor, with high mortality (30%) and moderate to severe disability in survivors despite the use of intravenous corticosteroids or immunoglobulins. ...

.. Ifosfamide-induced encephalopathy is a neurotoxic adverse effect of ifosfamide chemotherapy. The objective of this study was to determine the incidence of encephalopathy in patients with ...

.. brain encephalopathy, presenting as delirium, confusion, coma, and seizures in the immediate postoperative period.

OBJECTIVE: To determine the incidence, consequences, and predictive ...

.. 16) encephalopathy, in 15 normal volunteers, and in one patient with an opioid induced stupor state. Visual evoked potential parameters were classified on the basis of EEG recordings. ...

.. to encephalopathy in patients with chronic kidney disease (CKD).

Objective: To compare the 30-day risk of encephalopathy in patients with CKD and newly prescribed baclofen at greater than ...